CLINICAL_TRIALS
withdrawal
· 2025-05-23
Clinical Trial Update: Administration of Prazosin to Prevent PTSD in Adult Women After Sexual Assault [Phase 4]
Summary
A Phase 4 trial evaluating the use of prazosin to prevent posttraumatic stress disorder in adult women after sexual assault was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Posttraumatic Stress Disorder | Phase 4 | Status: WITHDRAWN